Coronary Microvascular Dysfunction

Coronary microvascular dysfunction can arise through several related mechanisms: endothelial dysfunction, impaired microvascular dilation, microvascular spasm, and structural remodeling. These abnormalities affect how the small vessels regulate myocardial blood flow, particularly when the heart needs more oxygen. Distinguishing among these mechanisms matters because the same clinical syndrome may reflect altered vessel signaling, excessive constriction, or changes in vessel structure.

During increased cardiac demand, inadequate microvascular dilation prevents blood flow from rising appropriately. The resulting mismatch between myocardial oxygen needs and delivery can produce ischemia and exertional symptoms, even without a major epicardial coronary obstruction. This explains why a patient’s symptoms may be genuine and physiologically meaningful despite apparently unobstructed large coronary arteries.

Assessment focused mainly on the major coronary arteries may not identify abnormalities in the smaller vessels. Consequently, patients can have angina, exertional symptoms, or abnormal stress-test results without significant large-vessel obstruction. Recognizing this distinction helps clinicians consider a microvascular explanation when findings suggest impaired myocardial blood supply but do not show the expected major arterial blockage.

Diagnosis generally combines functional testing, advanced cardiac imaging, and assessment of coronary flow reserve. These approaches provide complementary evidence when symptoms or stress-test findings suggest ischemia but the major coronary arteries lack significant obstruction. Using more than one assessment can help clinicians recognize a microvascular cause rather than dismissing the findings as noncardiac.

An abnormal stress-test result can indicate that myocardial blood flow becomes inadequate when cardiac demand rises, even if imaging does not show significant obstruction in the major coronary arteries. In that setting, the result may support further evaluation for a microvascular abnormality. This interpretation helps connect exertional symptoms with impaired blood-flow regulation rather than assuming a noncardiac origin.

Recognizing the condition gives clinicians a framework for addressing angina and exertional symptoms that may otherwise be attributed to noncardiac causes. Targeted management may improve symptoms and help reduce cardiovascular risk, according to the overview. The diagnosis therefore has value beyond labeling the symptoms: it can guide attention toward both patient comfort and longer-term cardiovascular care.